Science Explorer Back to mapMap
Institution · Kowa (Japan)

Most cited papers from Kowa (Japan)

What are the most cited papers from Kowa (Japan)?

The most cited paper from Kowa (Japan) is "Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk" (Aruna D. Pradhan et al., 2022), with 745 citations. Next come "Essential role for proteinase-activated receptor-2 in arthritis" (335) and "Preparation of undegraded native molecular fibroin solution from silkworm cocoons" (314).

Showing 50 of 59 papers. Every paper with more than 69 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk Aruna D. Pradhan et al. · New England Journal of Medicine Open access 5 Nov 2022 745
2 Essential role for proteinase-activated receptor-2 in arthritis William R. Ferrell, John C. Lockhart, Elizabeth B. Kelso et al. · Journal of Clinical Investigation Open access 2003 335
3 Preparation of undegraded native molecular fibroin solution from silkworm cocoons Hiromi Yamada, Hiroshi Nakao, Yoko Takasu et al. · Materials Science and Engineering C Aug 2001 314
4 Plasma thrombomodulin in health and diseases Shogo Takano, Shunsuke Kimura, Shinichi Ohdama et al. · Blood Open access 15 Nov 1990 302
5 Three‐dimensional spatial and temporal monitoring of soil water content using electrical resistivity tomography Qi Zhou, Jun Shimada, Akira Sato · Water Resources Research Open access Feb 2001 259
6 Dynamic Functional Relay between Insulin Receptor Substrate 1 and 2 in Hepatic Insulin Signaling during Fasting and Feeding Naoto Kubota et al. · Cell Metabolism Open access Jul 2008 250
7 Effects of K-877, a novel selective PPARα modulator (SPPARMα), in dyslipidaemic patients: A randomized, double blind, active- and placebo-controlled, phase 2 trial Shun Ishibashi, Shizuya Yamashita, Hidenori Arai et al. · Atherosclerosis Open access 26 Feb 2016 216
8 Randomised clinical trial: Pemafibrate, a novel selective peroxisome proliferator‐activated receptor α modulator (SPPARMα), versus placebo in patients with non‐alcoholic fatty liver disease Atsushi Nakajima, Yuichiro Eguchi, Masato Yoneda et al. · Alimentary Pharmacology & Therapeutics Open access 16 Sep 2021 211
9 Efficacy and safety of pemafibrate (K-877), a selective peroxisome proliferator-activated receptor α modulator, in patients with dyslipidemia: Results from a 24-week, randomized, double blind, active-controlled, phase 3 trial Shun Ishibashi, Hidenori Arai, Koutaro Yokote et al. · Journal of clinical lipidology Open access 28 Oct 2017 189
10 Effects of K-115 (Ripasudil), a novel ROCK inhibitor, on trabecular meshwork and Schlemm’s canal endothelial cells Yoshio A. Kaneko, M Ohta, Toshihiro Inoue et al. · Scientific Reports Open access 19 Jan 2016 172
11 The Effect of Statins on mRNA Levels of Genes Related to Inflammation, Coagulation, and Vascular Constriction in HUVEC. Shigeru Morikawa, Wakako Takabe, Chikage Mataki et al. · Journal of Atherosclerosis and Thrombosis Open access 2002 166
12 SLCO1B1 (OATP1B1, an Uptake Transporter) and ABCG2 (BCRP, an Efflux Transporter) Variant Alleles and Pharmacokinetics of Pitavastatin in Healthy Volunteers Ichiro Ieiri, Suttasinee Suwannakul, Kazuya Maeda et al. · Clinical Pharmacology & Therapeutics 25 Apr 2007 164
13 Effects of Pemafibrate, a Novel Selective PPARα Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Eiichi Araki, Shizuya Yamashita, Hidenori Arai et al. · Diabetes Care 3 Jan 2018 163
14 Rheology of Tear Film Lipid Layer Spread in Normal and Aqueous Tear–Deficient Dry Eyes Norihiko Yokoi, Hideaki Yamada, Mizukusa Yutaka et al. · Investigative Ophthalmology & Visual Science 26 Nov 2008 148
15 Structure and Expression of cDNA for an Inhibitor of Blood Coagulation Isolated from Human Placenta: A New Lipocortin-Like Protein Akio Iwasaki, Makoto Suda, Hiroshi Nakao et al. · The Journal of Biochemistry Nov 1987 146
16 Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial Hidenori Arai, Shizuya Yamashita, Koutaro Yokote et al. · Journal of Atherosclerosis and Thrombosis Open access 6 Apr 2018 137
17 One‐year clinical evaluation of 0.4% ripasudil (K‐115) in patients with open‐angle glaucoma and ocular hypertension Hidenobu Tanihara, Toshihiro Inoue, Tetsuya Yamamoto et al. · Acta Ophthalmologica Open access 4 Sep 2015 136
18 Efficacy and safety of K-877, a novel selective peroxisome proliferator-activated receptor α modulator (SPPARMα), in combination with statin treatment: Two randomised, double-blind, placebo-controlled clinical trials in patients with dyslipidaemia Hidenori Arai, Shizuya Yamashita, Koutaro Yokote et al. · Atherosclerosis Open access 24 Mar 2017 127
19 A selective ACAT-1 inhibitor, K-604, suppresses fatty streak lesions in fat-fed hamsters without affecting plasma cholesterol levels Mami Ikenoya, Yasunobu Yoshinaka, Hideyuki Kobayashi et al. · Atherosclerosis 6 Jul 2006 127
20 Additive Intraocular Pressure–Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost Hidenobu Tanihara, Toshihiro Inoue, Tetsuya Yamamoto et al. · JAMA Ophthalmology 16 Apr 2015 124
21 Effects of post-processing on cyclic fatigue response of a titanium alloy additively manufactured by electron beam melting Shui Xiaoli, Kenta Yamanaka, Manami Mori et al. · Materials Science and Engineering A 19 Oct 2016 118
22 Intra‐ocular pressure‐lowering effects of a Rho kinase inhibitor, ripasudil (K‐115), over 24 hours in primary open‐angle glaucoma and ocular hypertension: a randomized, open‐label, crossover study Hidenobu Tanihara, Toshihiro Inoue, Tetsuya Yamamoto et al. · Acta Ophthalmologica Open access 9 Dec 2014 117
23 Pemafibrate, a selective PPARα modulator, prevents non-alcoholic steatohepatitis development without reducing the hepatic triglyceride content Yusuke Sasaki, Masato Asahiyama, Toshiya Tanaka et al. · Scientific Reports Open access 8 May 2020 112
24 Effects of K-115, a Rho-Kinase Inhibitor, on Aqueous Humor Dynamics in Rabbits Tomoyuki Isobe, Ken Mizuno, Yoshio A. Kaneko et al. · Current Eye Research 6 Feb 2014 105
25 Histone Deacetylase Inhibitor Reduces Monocyte Adhesion to Endothelium Through the Suppression of Vascular Cell Adhesion Molecule-1 Expression Kenji Inoue, Mika Kobayashi, Kiichiro Yano et al. · Arteriosclerosis Thrombosis and Vascular Biology Open access 29 Sep 2006 105
26 Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Toshiaki Aoki, Hitoshi Nishimura, Shunji Nakagawa et al. · PubMed Aug 1997 104
27 Hepatic Sdf2l1 controls feeding-induced ER stress and regulates metabolism Takayoshi Sasako et al. · Nature Communications Open access 27 Feb 2019 104
28 Transporter-mediated influx and efflux mechanisms of pitavastatin, a new inhibitor of HMG-CoA reductase Hideki Fujino, Tsuyoshi Saito, Shinichiro Ogawa et al. · Journal of Pharmacy and Pharmacology Oct 2005 104
29 Automated segmentation of optic disc region on retinal fundus photographs: Comparison of contour modeling and pixel classification methods Chisako Muramatsu, Toshiaki Nakagawa, Akira Sawada et al. · Computer Methods and Programs in Biomedicine 24 May 2010 101
30 Neuroprotective effect and intraocular penetration of nipradilol, a beta-blocker with nitric oxide donative action. Ken Mizuno, Takaki Koide, Megumu Yoshimura et al. · PubMed Mar 2001 99
31 Statins suppress apolipoprotein CIII-induced vascular endothelial cell activation and monocyte adhesion Chunyu Zheng, Verónica Azcutia, Elena Aïkawa et al. · European Heart Journal Open access 26 Aug 2012 98
32 Metabolic properties of the acid and lactone forms of HMG-CoA reductase inhibitors Hideki Fujino, Takashi Saito, Yoshihiko Tsunenari et al. · Xenobiotica 2004 98
33 Enhanced transdermal delivery of indomethacin-loaded PLGA nanoparticles by iontophoresis Keishiro Tomoda, Hiroto Terashima, Kenichi Suzuki et al. · Colloids and Surfaces B Biointerfaces 23 Aug 2011 98
34 Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan Masato Yoneda, Takuma Yamamoto, Yasushi Honda et al. · Journal of Gastroenterology Open access 3 Oct 2021 96
35 LR11, a Mosaic LDL Receptor Family Member, Mediates the Uptake of ApoE-Rich Lipoproteins In Vitro Kouichi Taira, Hideaki Bujo, Satoshi Hirayama et al. · Arteriosclerosis Thrombosis and Vascular Biology Open access Sep 2001 96
36 Aerobic Mineralization of Hexachlorobenzene by Newly Isolated Pentachloronitrobenzene-Degrading Nocardioides sp. Strain PD653 Kazuhiro Takagi, Akio Iwasaki, Ichiro Kamei et al. · Applied and Environmental Microbiology Open access 9 May 2009 96
37 Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase: human UDP-glucuronosyltransferase enzymes involved in lactonization Hideki Fujino, Iwao Yamada, Shunsuke Shimada et al. · Xenobiotica 2003 95
38 Effects of Acid and Lactone Forms of Eight HMG-CoA Reductase Inhibitors on CYP-Mediated Metabolism and MDR1-Mediated Transport Toshiyuki Sakaeda, Hideki Fujino, Chiho Komoto et al. · Pharmaceutical Research Open access 31 Dec 2005 94
39 Effect of pitavastatin on apolipoprotein A-I production in HepG2 cell Takashi Maejima, Hiroyuki Yamazaki, Taro Aoki et al. · Biochemical and Biophysical Research Communications 5 Oct 2004 94
40 Principles and development of spatial filtering velocimetry Yoshihisa Aizu, T. Asakura · Applied Physics B Aug 1987 94
41 Effect of Protease-Activated Receptor-2 Deficiency on Allergic Dermatitis in the Mouse Ear Jun-ichi KAWAGOE, Toshiaki Takizawa, Jiro Matsumoto et al. · The Japanese Journal of Pharmacology Open access 2002 94
42 Expression and localization of P1 promoter-driven hepatocyte nuclear factor-4α (HNF4α) isoforms in human and rats Shuying Sue Jiang, Toshiya Tanaka, Hiroko Iwanari et al. · Nuclear Receptor Open access 8 Aug 2003 92
43 Cross-enhancement of ANGPTL4 transcription by HIF1 alpha and PPAR beta/delta is the result of the conformational proximity of two response elements Tsuyoshi Inoue et al. · Genome biology Open access 10 Apr 2014 86
44 Design and synthesis of highly potent and selective human peroxisome proliferator-activated receptor α agonists Y. Yamazaki, Kazutoyo Abe, Tsutomu Toma et al. · Bioorganic & Medicinal Chemistry Letters Open access 25 May 2007 84
45 Comparative long‐term efficacy and tolerability of pitavastatin 4 mg and atorvastatin 20–40 mg in patients with type 2 diabetes mellitus and combined (mixed) dyslipidaemia Jakub Janusz Gumprecht, Masahiko Gosho, Dragos Budinski et al. · Diabetes Obesity and Metabolism 3 Aug 2011 83
46 Canine corneal thickness measured by ultrasonic pachymetry Brian C. Gilger, R. David Whitley, Susan A. McLaughlin et al. · American Journal of Veterinary Research Open access Oct 1991 80
47 Long-term safety and efficacy of tofogliflozin, a selective inhibitor of sodium-glucose cotransporter 2, as monotherapy or in combination with other oral antidiabetic agents in Japanese patients with type 2 diabetes mellitus: multicenter, open-label, randomized controlled trials Yukio Tanizawa, Kohei Kaku, Eiichi Araki et al. · Expert Opinion on Pharmacotherapy 11 Feb 2014 80
48 Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-α Modulator (SPPARMα), in Dyslipidemic Patients with Renal Impairment Koutaro Yokote, Shizuya Yamashita, Hidenori Arai et al. · International Journal of Molecular Sciences Open access 6 Feb 2019 79
49 Correlation of morphologic features of the iridocorneal angle to intraocular pressure in Samoyeds Björn Ehesten, Kristina L. Narfström · American Journal of Veterinary Research Open access Nov 1991 79
50 Relative Induction of mRNA for HMG CoA Reductase and LDL Receptor by Five Different HMG-CoA Reductase Inhibitors in Cultured Human Cells Shigeru Morikawa, Michihisa Umetani, Shunji Nakagawa et al. · Journal of Atherosclerosis and Thrombosis Open access 2000 78

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.